等待开盘
0.000
NaN.00%
Semnur Pharmaceuticals, Inc. ("Semnur"), a majority-owned subsidiary of Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and
09-04 21:05
Denali Capital Acquisition Corp Class A ( ($DNQAF) ) just unveiled an announcem...
07-29 04:57
Denali Capital Acquisition Corp. Class A ( ($DECA) ) has released a notificatio...
04-01 20:24
转自:新康界 2024年9月,在生物医药领域,有7家公司采取IPO形式上市,5家公司SPAC合并上市。 一、IPO上市 9月是生物医药公司IPO的传统旺季,共有...
2024-10-28 17:51
Denali Capital Acquisition: Combined Co to Be Renamed Semnur Pharmaceuticals, I...
2024-09-03 21:03
Denali Capital Acquisition: Scilex Expected to Be Majority Holder of Combined C...
2024-09-03 21:02
Denali Capital Acquisition Corp: Pre-Transaction Equity Value of Semnur at $2.5...
2024-09-03 21:01
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Compa...
2024-09-03 21:00
Scilex Holding (NASDAQ:SCLX) files preliminary prospectus to offer and sell, by the selling securityholders, of up to 3,500,000 shares of common stock. SEC Filing More on Scilex Holding Company Semnu...
2024-07-19 04:34
Denali Capital Acquisition Corp - Extends Business Combination Deadline to Apri...
2024-07-11 04:32